This public announcement seeks to notify public health and public safety, law enforcement, clinicians, medical examiners and coroners, laboratory personnel, drug treatment providers, and other related communities about new information about the emergent synthetic opioid, protonitazene.
This brief document provides information about the emergent synthetic opioid, protonitazene, which was first identified in the U.S. toxicology samples in the May 2021. The document provides a general background about synthetic opioids, noting that this new opioid exhibits potency similar to other recently emergent “nitazene” opioids and approximately three times more potent than fentanyl. The announcement also provides demographic information about users, including age and sex, and geographical distribution in the U.S. The fact sheet also depicts the structure of the protonitazene molecule; provides recommendations for public health, clinicians, medical examiners and coroners, and laboratories; and informs that NPS rapid testing is now available.
Downloads
Similar Publications
- Decoding Disbelief: Using Natural Language Processing's Sentiment Analysis to Assess 24 Years of Unfounded Rape Reports Narratives
- The Impact of Identity and Population History on Population Affinity Analysis in New Mexico Using Cranial Macromorphoscopic Data
- Progressive examination of footwear outsoles throughout a 24-week police training academy